<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00250380</url>
  </required_header>
  <id_info>
    <org_study_id>H17-CV(Seishu)-002</org_study_id>
    <nct_id>NCT00250380</nct_id>
  </id_info>
  <brief_title>The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)</brief_title>
  <official_title>The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)ÔºçA Prospective Multicenter Cohort Study-</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ministry of Health, Labour and Welfare, Japan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The National Institute of Biomedical Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ministry of Health, Labour and Welfare, Japan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the clinically meaningful definition and prevalence
      of aspirin resistance based on data linking aspirin-dependent laboratory tests to recurrent
      vascular events in cardiovascular patients taking aspirin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Outcomes: The primary endpoint is the composite outcomes of cerebral infarction,
      transient ischemic attack, myocardial infarction, unstable angina, percutaneous coronary
      angiography, thromboembolism, and death caused by cardiovascular disease.

      Secondary Outcomes: Platelet aggregation induced by collagen and arachidonic acid, serum
      thromboxane B2, urine 11-dehydrothromboxane B2, platelet thrombus formation under flow
      conditions (sub-study only at the National Cardiovascular Center)

      The primary objective of this study is to determine the markers for aspirin resistance. To
      achieve this objective, platelet aggregation, serum thromboxane B2, and urine
      11-dehydrothromboxane B2 are measured in patients receiving usual therapeutic doses of
      aspirin, who experienced acute coronary syndrome, cerebral infarction, or transient ischemic
      attack occurred in a period between the past 1 month and the past 2 years. This is a
      multi-center, prospective study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">583</enrollment>
  <condition>Coronary Disease</condition>
  <condition>Cerebral Infarction</condition>
  <condition>Ischemic Attack, Transient</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        out-patient clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult males or females who met the criteria listed below:

          -  Patients who had acute coronary syndrome, cerebral infarction (except cardioembolic
             stroke), or transient ischemic attack between past 28 days and the past 2 years

          -  patients who receive long-term aspirin therapy (at least 28 days)

          -  Patients who are &gt;=20 years of age

          -  Patients willing and able to give written informed consent

        Exclusion Criteria:

          -  Malignancy or suspected malignancy

          -  Patients who showed platelet counts less than 100,000/uL or more than 450,000/uL

          -  Congenital bleeding tendency

          -  Patients who receive other antiplatelet drugs or warfarin

          -  Patients with atrial fibrillation

          -  Patients who received surgical operation or catheter intervention within the past 2
             weeks

          -  Patients who received anticoagulation drug therapy including heparin ( low-molecular
             weight heparin) and danaparoid.

          -  Patients with more than modified Rankin scale 4
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toshiyuki Miyata, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cardiovascular Center, Research Institute,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shigeki Miyata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kazuo Minematsu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masafumi Kitakaze, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kazuyuki Nagatsuka, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Atsushi Kawamura, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Akiko Kada, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cerebral and Cardiovascular Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shinichiro Uchiyama, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tokyo Women's Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takehiko Nagao, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tokyo Metropolitan Ebara Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naohisa Hosomi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kagawa University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takemori Yamawaki, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nagoya City University Graduate School of Medical Science</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kazumi Kimura, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kawasaki Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kozue Saito, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nara Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hiroshi Nakane, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Fukuoka-Higashi Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jyoji Nakagawara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nakamura Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shinya Goto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tokai University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takaaki Isshiki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Teikyo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kazuo Kitagawa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Osaka University Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kazuomi Kario, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jichi Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hideo Wada, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mie University Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ken Nagata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Institute for Brain and Blood Vessels Akita</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Koichi Kaikita, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kumamoto University Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Keiji Tanaka, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nippon Medical School Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Akira Hattori, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sado Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eisuke Furui, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kohnan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yoshihiko Saito, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nara Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Satoshi Ueno, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nara Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yasuo Katayama, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nippon Medical School Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Takeo Abumiya, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hokkaido Neurosurgical Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masakatsu Nishikawa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mie University Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shin Takiuchi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Higashi Takarazuka Satoh Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hideyuki Ohnishi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohnishi Neurological Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Fukuoka-Higashi Medical Center</name>
      <address>
        <city>Koga</city>
        <state>Fukuoka</state>
        <zip>8113195</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hokkaido Neurosurgical Memorial Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>0600022</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakamura Memorial Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>0600061</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohnishi Neurological Center</name>
      <address>
        <city>Akashi</city>
        <state>Hyogo</state>
        <zip>674-0064</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Higashi Takarazuka Satoh Hospital</name>
      <address>
        <city>Takarazuka</city>
        <state>Hyogo</state>
        <zip>6650973</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kagawa University School of Medicine</name>
      <address>
        <city>Kida-gun</city>
        <state>Kagawa</state>
        <zip>7610793</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokai University School of Medicine</name>
      <address>
        <city>Isehara</city>
        <state>Kanagawa</state>
        <zip>2591193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mie University Graduate School of Medicine</name>
      <address>
        <city>Tsu</city>
        <state>Mie</state>
        <zip>5148507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kohnan Hospital</name>
      <address>
        <city>Sendai</city>
        <state>Miyagi</state>
        <zip>9828523</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nara Medical University</name>
      <address>
        <city>Kashihara</city>
        <state>Nara</state>
        <zip>6348521</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sado Hospital</name>
      <address>
        <city>Sado</city>
        <state>Niigata</state>
        <zip>9521209</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kawasaki Medical School</name>
      <address>
        <city>Kurashiki</city>
        <state>Okayama</state>
        <zip>7010192</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka University Graduate School of Medicine</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>5650871</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cardiovascular Center</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>5658565</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Ureshino Medical Center</name>
      <address>
        <city>Fujitsu-gun</city>
        <state>Saga</state>
        <zip>8430393</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jichi Medical School</name>
      <address>
        <city>Kawachi-gun</city>
        <state>Tochigi</state>
        <zip>3290498</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Institute for Brain and Blood Vessels Akita</name>
      <address>
        <city>Akita</city>
        <zip>0100874</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kumamoto University Graduate School of Medicine</name>
      <address>
        <city>Kumamoto</city>
        <zip>8608556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nagoya City University Graduate School of Medical Sciences</name>
      <address>
        <city>Nagoya</city>
        <zip>4678602</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nippon Medical School Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>1138603</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Metropolitan Ebara Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>1450065</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Women's Medical University</name>
      <address>
        <city>Tokyo</city>
        <zip>1628666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Teikyo University</name>
      <address>
        <city>Tokyo</city>
        <zip>1738606</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2005</study_first_submitted>
  <study_first_submitted_qc>November 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2005</study_first_posted>
  <last_update_submitted>December 12, 2011</last_update_submitted>
  <last_update_submitted_qc>December 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cerebral and Cardiovascular Center</investigator_affiliation>
    <investigator_full_name>Toshiyuki Miyata</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Aspirin</keyword>
  <keyword>Platelet Aggregation Inhibitors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Platelet Aggregation Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

